CA2487232C - Systeme de stockage de donnes medicales securisees accessibles sur une carte sante individuelle - Google Patents

Systeme de stockage de donnes medicales securisees accessibles sur une carte sante individuelle Download PDF

Info

Publication number: CA2487232C
Authority: CA; Canada
Prior art keywords: patient; meter; memory storage; medical records; removable memory
Prior art date: 1998-11-09
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

CA002487232A

Other languages

English (en)

Other versions

CA2487232A1 (fr

Inventor

Kenn A. Nesbitt

James L. Moody

Christopher T. Maus

Jackson B. Connolly

Noah M. Coad

Craig A. Coad

Kenneth D. Clegg

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Orangehook Inc

Original Assignee

LifeNexus Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-11-09

Filing date

1999-11-08

Publication date

2009-10-20

1999-11-08 Application filed by LifeNexus Inc filed Critical LifeNexus Inc

1999-11-08 Priority claimed from CA002350145A external-priority patent/CA2350145C/fr

2000-05-18 Publication of CA2487232A1 publication Critical patent/CA2487232A1/fr

2009-10-20 Application granted granted Critical

2009-10-20 Publication of CA2487232C publication Critical patent/CA2487232C/fr

2019-11-08 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

230000036541 health Effects 0.000 title claims abstract description 175
238000013500 data storage Methods 0.000 title claims description 8
238000012544 monitoring process Methods 0.000 claims abstract description 31
238000004458 analytical method Methods 0.000 claims abstract description 22
238000012423 maintenance Methods 0.000 claims description 80
230000005055 memory storage Effects 0.000 claims description 69
238000000034 method Methods 0.000 claims description 45
238000012806 monitoring device Methods 0.000 claims description 34
230000000875 corresponding effect Effects 0.000 claims description 27
238000004891 communication Methods 0.000 claims description 19
238000010200 validation analysis Methods 0.000 claims description 16
230000002596 correlated effect Effects 0.000 claims description 4
238000012360 testing method Methods 0.000 abstract description 264
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 112
239000008280 blood Substances 0.000 abstract description 40
210000004369 blood Anatomy 0.000 abstract description 39
235000012000 cholesterol Nutrition 0.000 abstract description 36
230000000747 cardiac effect Effects 0.000 abstract description 15
208000019622 heart disease Diseases 0.000 abstract description 10
230000004580 weight loss Effects 0.000 abstract description 5
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 4
239000004973 liquid crystal related substance Substances 0.000 abstract description 3
238000012502 risk assessment Methods 0.000 abstract description 2
238000010586 diagram Methods 0.000 description 42
230000004913 activation Effects 0.000 description 38
239000003814 drug Substances 0.000 description 16
229940079593 drug Drugs 0.000 description 16
239000000523 sample Substances 0.000 description 12
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 11
239000008103 glucose Substances 0.000 description 11
230000036772 blood pressure Effects 0.000 description 10
238000002560 therapeutic procedure Methods 0.000 description 9
238000002651 drug therapy Methods 0.000 description 8
230000008569 process Effects 0.000 description 8
238000003860 storage Methods 0.000 description 8
210000001519 tissue Anatomy 0.000 description 8
239000013060 biological fluid Substances 0.000 description 7
206010012601 diabetes mellitus Diseases 0.000 description 7
208000010125 myocardial infarction Diseases 0.000 description 7
230000003287 optical effect Effects 0.000 description 7
238000004806 packaging method and process Methods 0.000 description 7
239000012472 biological sample Substances 0.000 description 6
150000002632 lipids Chemical class 0.000 description 6
208000030507 AIDS Diseases 0.000 description 5
206010028980 Neoplasm Diseases 0.000 description 5
208000006011 Stroke Diseases 0.000 description 5
238000013475 authorization Methods 0.000 description 5
201000011510 cancer Diseases 0.000 description 5
238000013479 data entry Methods 0.000 description 5
210000003296 saliva Anatomy 0.000 description 5
235000005911 diet Nutrition 0.000 description 4
235000013305 food Nutrition 0.000 description 4
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
238000012546 transfer Methods 0.000 description 4
230000003213 activating effect Effects 0.000 description 3
230000008901 benefit Effects 0.000 description 3
230000037029 cross reaction Effects 0.000 description 3
230000037213 diet Effects 0.000 description 3
235000019007 dietary guidelines Nutrition 0.000 description 3
235000020979 dietary recommendations Nutrition 0.000 description 3
230000008520 organization Effects 0.000 description 3
230000004044 response Effects 0.000 description 3
238000012795 verification Methods 0.000 description 3
230000000007 visual effect Effects 0.000 description 3
208000010496 Heart Arrest Diseases 0.000 description 2
102000004877 Insulin Human genes 0.000 description 2
108090001061 Insulin Proteins 0.000 description 2
241001441724 Tetraodontidae Species 0.000 description 2
230000003190 augmentative effect Effects 0.000 description 2
230000005540 biological transmission Effects 0.000 description 2
230000005189 cardiac health Effects 0.000 description 2
230000008859 change Effects 0.000 description 2
230000001276 controlling effect Effects 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
238000012774 diagnostic algorithm Methods 0.000 description 2
230000000694 effects Effects 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
230000006870 function Effects 0.000 description 2
229940125396 insulin Drugs 0.000 description 2
239000002547 new drug Substances 0.000 description 2
230000035935 pregnancy Effects 0.000 description 2
238000007639 printing Methods 0.000 description 2
238000012545 processing Methods 0.000 description 2
230000000391 smoking effect Effects 0.000 description 2
SPJOZZSIXXJYBT-UHFFFAOYSA-N Fenson Chemical compound C1=CC(Cl)=CC=C1OS(=O)(=O)C1=CC=CC=C1 SPJOZZSIXXJYBT-UHFFFAOYSA-N 0.000 description 1
208000035150 Hypercholesterolemia Diseases 0.000 description 1
238000008214 LDL Cholesterol Methods 0.000 description 1
241001310793 Podium Species 0.000 description 1
101100194363 Schizosaccharomyces pombe (strain 972 / ATCC 24843) res2 gene Proteins 0.000 description 1
210000000577 adipose tissue Anatomy 0.000 description 1
239000012491 analyte Substances 0.000 description 1
239000003529 anticholesteremic agent Substances 0.000 description 1
238000013459 approach Methods 0.000 description 1
230000006399 behavior Effects 0.000 description 1
150000001768 cations Chemical class 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
238000007705 chemical test Methods 0.000 description 1
239000013078 crystal Substances 0.000 description 1
238000013461 design Methods 0.000 description 1
238000001514 detection method Methods 0.000 description 1
230000000378 dietary effect Effects 0.000 description 1
235000008242 dietary patterns Nutrition 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
238000009826 distribution Methods 0.000 description 1
230000001037 epileptic effect Effects 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
238000009207 exercise therapy Methods 0.000 description 1
238000000605 extraction Methods 0.000 description 1
239000012530 fluid Substances 0.000 description 1
230000036449 good health Effects 0.000 description 1
230000005802 health problem Effects 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
239000007788 liquid Substances 0.000 description 1
210000004072 lung Anatomy 0.000 description 1
238000007726 management method Methods 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
101150037117 pct-1 gene Proteins 0.000 description 1
238000012123 point-of-care testing Methods 0.000 description 1
239000000955 prescription drug Substances 0.000 description 1
230000003449 preventive effect Effects 0.000 description 1
230000001850 reproductive effect Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
230000029058 respiratory gaseous exchange Effects 0.000 description 1
235000000891 standard diet Nutrition 0.000 description 1
239000013589 supplement Substances 0.000 description 1
150000003626 triacylglycerols Chemical class 0.000 description 1

Landscapes

Medical Treatment And Welfare Office Work (AREA)
Measuring And Recording Apparatus For Diagnosis (AREA)

CA002487232A 1998-11-09 1999-11-08 Systeme de stockage de donnes medicales securisees accessibles sur une carte sante individuelle Expired - Lifetime CA2487232C (fr)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US10770498P	1998-11-09	1998-11-09
US60/107,704		1998-11-09
US14470599P	1999-07-20	1999-07-20
US60/144,705		1999-07-20
CA002350145A CA2350145C (fr)	1998-11-09	1999-11-08	Dispositif de controle de l'etat de sante et de diagnostic et systeme d'evaluation de l'etat de sante et d'actualisation de dossiers medicaux construit en reseau

Related Parent Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002350145A Division CA2350145C (fr)	1998-11-09	1999-11-08	Dispositif de controle de l'etat de sante et de diagnostic et systeme d'evaluation de l'etat de sante et d'actualisation de dossiers medicaux construit en reseau

Publications (2)

Publication Number	Publication Date
CA2487232A1 CA2487232A1 (fr)	2000-05-18
CA2487232C true CA2487232C (fr)	2009-10-20

Family

ID=34139154

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002487232A Expired - Lifetime CA2487232C (fr)	1998-11-09	1999-11-08	Systeme de stockage de donnes medicales securisees accessibles sur une carte sante individuelle

Country Status (1)

Country	Link
CA (1)	CA2487232C (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB201312998D0 (en) *	2013-07-19	2013-09-04	Cambridge temperature concepts ltd	Acquiring reliable data
US10827941B2 (en) *	2017-12-06	2020-11-10	General Electric Company	System and methods for qualification of ECG data for remote analysis
CN111243719B (zh) *	2020-01-14	2023-06-06	北京唐颐惠康生物医学技术有限公司	分布式云健康管理方法及系统
CN114157474B (zh) *	2021-11-30	2024-02-23	杭州趣链科技有限公司	一种匿名性和不可跟踪性的在线健康信息获取方法

1999
- 1999-11-08 CA CA002487232A patent/CA2487232C/fr not_active Expired - Lifetime

Also Published As

Publication number	Publication date
CA2487232A1 (fr)	2000-05-18

Legal Events

Date	Code	Title	Description
2004-11-10	EEER	Examination request
2020-01-12	MKEX	Expiry	Effective date: 20191108

Publication	Publication Date	Title
CA2350145C (fr)	2005-02-08	Dispositif de controle de l'etat de sante et de diagnostic et systeme d'evaluation de l'etat de sante et d'actualisation de dossiers medicaux construit en reseau
US7424437B2 (en)	2008-09-09	Personal health card accessed secure medical data storage system
US8239627B2 (en)	2012-08-07	Smartcard accessed dual server electronic data storage system
JP4999687B2 (ja)	2012-08-15	医療データ管理システムおよび方法
US9390458B2 (en)	2016-07-12	Network for health management and mobile device controlled access
US8534549B2 (en)	2013-09-17	Network for blood pressure data management and rechargeable smart card
WO2013136600A1 (fr)	2013-09-19	Serveur de distribution d'informations biométriques, programme associé et système d'aide médicale utilisant ledit serveur
CA2487232C (fr)	2009-10-20	Systeme de stockage de donnes medicales securisees accessibles sur une carte sante individuelle
CA2618976C (fr)	2017-01-03	Procede et appareil d'enregistrement de la pression arterielle sur carte intelligente rechargeable
AU2017276320A1 (en)	2018-01-18	Network for blood pressure data management, and rechargeable smart card
AU2009248794A1 (en)	2009-11-26	Network for blood pressure data management, and rechargeable smart card